DK0922453T3 - Tulobuterolholdigt præparat til perkutan absorption - Google Patents

Tulobuterolholdigt præparat til perkutan absorption

Info

Publication number
DK0922453T3
DK0922453T3 DK98123314T DK98123314T DK0922453T3 DK 0922453 T3 DK0922453 T3 DK 0922453T3 DK 98123314 T DK98123314 T DK 98123314T DK 98123314 T DK98123314 T DK 98123314T DK 0922453 T3 DK0922453 T3 DK 0922453T3
Authority
DK
Denmark
Prior art keywords
percutaneous absorption
tulobuterol
time
preparation
drug
Prior art date
Application number
DK98123314T
Other languages
English (en)
Inventor
Yoshihisa Nakano
Mitsuhiko Hori
Keiji Yamamoto
Saburo Otsuka
Original Assignee
Nitto Denko Corp
Abbott Japan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp, Abbott Japan Co Ltd filed Critical Nitto Denko Corp
Application granted granted Critical
Publication of DK0922453T3 publication Critical patent/DK0922453T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
DK98123314T 1997-12-12 1998-12-08 Tulobuterolholdigt præparat til perkutan absorption DK0922453T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34258297 1997-12-12
JP30449898A JP3930984B2 (ja) 1997-12-12 1998-10-26 経皮吸収型製剤

Publications (1)

Publication Number Publication Date
DK0922453T3 true DK0922453T3 (da) 2005-11-07

Family

ID=26563935

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98123314T DK0922453T3 (da) 1997-12-12 1998-12-08 Tulobuterolholdigt præparat til perkutan absorption

Country Status (15)

Country Link
US (1) US6117447A (da)
EP (1) EP0922453B1 (da)
JP (1) JP3930984B2 (da)
KR (1) KR100610185B1 (da)
CN (1) CN1129426C (da)
AT (1) ATE305775T1 (da)
BR (1) BR9806470B1 (da)
CA (1) CA2255447C (da)
DE (1) DE69831785T2 (da)
DK (1) DK0922453T3 (da)
ES (1) ES2246062T3 (da)
HK (1) HK1022091A1 (da)
HU (1) HU227974B1 (da)
PL (1) PL194195B1 (da)
PT (1) PT922453E (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3930984B2 (ja) * 1997-12-12 2007-06-13 日東電工株式会社 経皮吸収型製剤
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
JP3711846B2 (ja) * 2000-07-27 2005-11-02 株式会社村田製作所 高周波モジュール及びそれを用いた移動体通信装置
WO2002052951A1 (en) * 2000-12-29 2002-07-11 Martin Francis Gannon An animal food product
KR100439659B1 (ko) * 2001-06-23 2004-07-12 제일약품주식회사 툴로부테롤을 함유하는 경피흡수용 패취제
KR100535302B1 (ko) * 2002-02-01 2005-12-08 주식회사 태평양 툴로부테롤 함유 경피흡수형 제제
KR100469995B1 (ko) * 2002-05-20 2005-02-05 안국약품 주식회사 천식치료제를 함유한 매트릭스형 패취
JP2004224701A (ja) * 2003-01-17 2004-08-12 Yuutoku Yakuhin Kogyo Kk 外用貼付剤
JP2004224741A (ja) * 2003-01-23 2004-08-12 Hisamitsu Pharmaceut Co Inc ツロブテロール経皮吸収型製剤
JP4617069B2 (ja) * 2003-06-16 2011-01-19 コスメディ製薬株式会社 貼付剤
US8029820B2 (en) 2003-06-20 2011-10-04 Teikoku Seiyaku Co., Ltd. Patches containing tulobuterol
US20070077285A1 (en) * 2003-11-21 2007-04-05 Hiroko Udagawa Adhesive skin patch
CN1297257C (zh) * 2004-01-02 2007-01-31 上海现代药物制剂工程研究中心有限公司 含有妥洛特罗的压敏胶，透皮贴剂及制备方法和应用
US7939100B2 (en) 2004-01-20 2011-05-10 Saitama Daiichi Pharmaceutical Co., Ltd. Tulobuterol adhesive patch
KR100579721B1 (ko) 2004-09-15 2006-05-15 (주) 에프디엘 툴로부테롤을 함유하는 경피투여용 패취제
JP2006206471A (ja) * 2005-01-26 2006-08-10 Nitto Denko Corp テープ製剤
US7700659B2 (en) * 2005-03-24 2010-04-20 Advanced Cardiovascular Systems, Inc. Implantable devices formed of non-fouling methacrylate or acrylate polymers
US9381279B2 (en) 2005-03-24 2016-07-05 Abbott Cardiovascular Systems Inc. Implantable devices formed on non-fouling methacrylate or acrylate polymers
JP5058531B2 (ja) * 2005-09-09 2012-10-24 日東電工株式会社 ビソプロロール含有貼付製剤
JP4945228B2 (ja) 2005-12-13 2012-06-06 日東電工株式会社 ビソプロロール含有貼付製剤
WO2008108424A1 (ja) * 2007-03-08 2008-09-12 Nitto Denko Corporation ビソプロロール経皮投与デバイス
KR100956023B1 (ko) * 2007-09-28 2010-05-06 대화제약 주식회사 산성 관능기를 갖는 아크릴레이트계 고분자의 함량으로약물 방출속도를 제어하는 툴로부테롤 경피 투여용 패취제
JP2009286707A (ja) * 2008-05-27 2009-12-10 Nitto Denko Corp 医療材料又は衛生材料用のゲル組成物、その成形体及びそれを用いた貼付材もしくは貼付製剤
JP5432613B2 (ja) * 2008-07-17 2014-03-05 日東電工株式会社 貼付剤および貼付製剤
JP5432614B2 (ja) 2008-07-17 2014-03-05 日東電工株式会社 貼付剤および貼付製剤
JP2010241746A (ja) * 2009-04-07 2010-10-28 Nitto Denko Corp 貼付剤および貼付製剤
JP5404145B2 (ja) * 2009-04-10 2014-01-29 日東電工株式会社 貼付剤および貼付製剤
JP5766475B2 (ja) * 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
EP2667861A4 (en) * 2011-01-26 2014-07-16 Csi Gmbh TRANSDERMAL PROLONGED RELEASE PATCHES ASSOCIATING A BETA-AGONIST AND ANTICHOLINERGIC AND METHODS OF USE
WO2012103015A2 (en) * 2011-01-27 2012-08-02 Csi Gmbh Extended-release beta agonist/steroid transdermal patches and methods for using the same
CN103127032A (zh) * 2011-11-30 2013-06-05 大化制药株式会社 妥洛特罗贴剂
CN108785286A (zh) * 2017-04-28 2018-11-13 日东电工株式会社 透皮吸收制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
JPH0725669B2 (ja) * 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
IT1251469B (it) * 1991-07-15 1995-05-15 Zambon Spa Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante.
JP2753800B2 (ja) * 1994-04-14 1998-05-20 日東電工株式会社 経皮吸収型製剤
JP3604177B2 (ja) * 1994-09-14 2004-12-22 日東電工株式会社 経皮吸収製剤
JPH08295624A (ja) * 1995-04-26 1996-11-12 Read Chem Kk プラスター基剤、その製造方法、該基剤を使用した外用貼 付剤
JP3930984B2 (ja) * 1997-12-12 2007-06-13 日東電工株式会社 経皮吸収型製剤

Also Published As

Publication number Publication date
CA2255447C (en) 2006-01-24
PL194195B1 (pl) 2007-05-31
EP0922453B1 (en) 2005-10-05
EP0922453A3 (en) 1999-11-24
HUP9802889A3 (en) 2001-04-28
BR9806470A (pt) 2000-04-11
JPH11228395A (ja) 1999-08-24
KR19990062986A (ko) 1999-07-26
PL330212A1 (en) 1999-06-21
KR100610185B1 (ko) 2006-11-30
BR9806470B1 (pt) 2012-03-20
JP3930984B2 (ja) 2007-06-13
CA2255447A1 (en) 1999-06-12
CN1129426C (zh) 2003-12-03
ES2246062T3 (es) 2006-02-01
HUP9802889A2 (hu) 1999-06-28
PT922453E (pt) 2005-11-30
HU227974B1 (en) 2012-07-30
DE69831785D1 (de) 2006-02-16
EP0922453A2 (en) 1999-06-16
HK1022091A1 (en) 2000-07-28
US6117447A (en) 2000-09-12
ATE305775T1 (de) 2005-10-15
DE69831785T2 (de) 2006-07-13
HU9802889D0 (en) 1999-02-01
CN1226422A (zh) 1999-08-25

Similar Documents

Publication Publication Date Title
DK0922453T3 (da) Tulobuterolholdigt præparat til perkutan absorption
DK0740650T3 (da) Codrugs som metode til styret transport af lægemiddel
ATE184473T1 (de) Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
CY1117668T1 (el) Φαρμακευτικες συστασεις περιλαμβανουσες ινσουλινη συμπλοκοποιημενη με μια δικετοπιπεραζινη
DK0674913T3 (da) Ikke-okklusivt klæbende plaster til påföring af medicament i huden
DK0641561T3 (da) Medicinsk anordning til indgivelse af aktive bestanddele eller medikamenter i meget lave doser, specielt homøopatiske medik
KR950702827A (ko) 부프로피온 함유 서방형 정제(sustained release tablets containing bupropion)
DE3881340D1 (de) Vorrichtung zur transdermalen applikation von medikamenten.
ES2030026T3 (es) Sistema terapeutico transdermal, su aplicacion y procedimiento para su fabricacion.
DK0831827T3 (da) Nye formuleringer til transdermal levering af pergolid
DK0974350T3 (da) Tranilast-holdigt præparat til ydre påføring og fremgangsmåde til fremstilling af dette
BR0208005A (pt) Preparação para adesivo tópico contendo indutor de hipersensibilidade do tipo retardado e processos para a utilização do mesmo
DK58387A (da) Farmaceutiske praeparatformer til stabilisering af interferon-alfa, deres anvendelse og fremgangsmaade til deres fremstilling
PT1063983E (pt) Sistema terapeutico transdermico (tts) contendo oxibutinina
WO1994017792A3 (en) Compositions and methods for transdermal drug delivery
DE69133077T2 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
JPS6468316A (en) External plaster containing salbutamol
WO2001026637A3 (de) Transdermales therapeutisches system zur abgabe von acetylsalicylsäure und/oder salicylsäure
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente
DE69706070D1 (de) Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazol
SE0103276D0 (sv) Anordning för administrering av salva till en hudyta
DE59910944D1 (de) Transdermales therapeutisches system zur anwendung von candesartan
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
LV10749A (lv) Transdermala terapeitiska sistema fizostigmina uzliksanai uz adas un tas izgatavosanas panemiens